Teneligliptin (MP-513) hydrobromide is a potent chemotype prolylthiazolidine-based DPP-4 inhibitor, which competitively inhibits human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50s of approximately 1 nM.
DPP-4 Inhibitor Related Products:
Alogliptin benzoate; Sitagliptin phosphate monohydrate; Linagliptin; Vildagliptin; Saxagliptin; Trelagliptin succinate; Omarigliptin; Saxagliptin hydrate; Trelagliptin; Saxagliptin HCL; Alogliptin